Optimisation of combined therapy and clinico-laboratory control of children with bronchial asthma, using formoterol

Capa

Citar

Texto integral

Resumo

Searching for exact ways and scheme of treatment and supervising asthma patients on long-acting form of b 2-agonist (Formoterol) therapy is still very actual. We studied 31 children (from 7 to 11 years) with moderate non-controled bronchial asthma during 12 weeks. As a basic therapy inhaled corticosteroids-mono or in a combination with Foradyle were used. Corresponding data on Childhood Asthma Control Test, lung function, electrocardiogram, serum potassium and glucose concentrations were monitoring clinically. No adverse reactions were seen. The results obtained for the case of combined therapy with formoterol point out the necessity of more frequent than prescribed observation of the patient state trend, with taking electrocardiography and especially compliance into account.

Sobre autores

L Puschko

Peoples' Friendship University of Russia

Department of Pediatrics

O Alekseeva

Peoples' Friendship University of Russia

Department of Pediatrics

T Brilkova

Peoples' Friendship University of Russia

Department of Pediatrics

T Nazarova

Peoples' Friendship University of Russia

Department of Pediatrics

T Oboladze

Peoples' Friendship University of Russia

Email: rudnvestnik@yandex.ru
Department of Pediatrics

E Samitova

Morozov Children Hospital

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).